Amarin Corp Plc (AMRN)

[Whalatane]

Mrmain . Good idea to follow up with Co .

Could you ask them to clarify the following .

Re Exclusions

13. Use of non–study-drug-related, nonstatin lipid-altering medications, dietary supplements, or foods during the screening period (after Visit 1) and/or plans for use during the treatment/follow-up period, including:
----------------------------

Did they exclude Jardiance use by diabetics in this trial ...after Jardiance was approved late 2014 .

From what I have read it appears Jardiance is associated with small changes in HDL and LDL but theres no definitive proof ( that I've found ) that it causes lipid alterations ....so I'm wondering if they allowed US diabetics in R-IT to add that to standard of care ...or not .
Thx
Kiwi

PS . note CV risk reduction

http://www.nejm.org/doi/full/10.1056/NEJMoa1504720